LONGEVRA◆ LAB
Tirzepatide
GLP-1/GIP Dual Agonist · Lyophilized
PURITY≥ 99%
METHODHPLC
LOT2605-12
EXP2027-06
30 mg
99% PURE
HPLC VERIFIED
NET 30mg
FOR RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
Tirzepatide · LONGEVRA
LONGEVRA · RESEARCH GRADE

Tirzepatide (GLP-1/GIP) 30MG

Tirzepatide (GLP-1/GIP) 30MG

$185.00

For Research Use Only — Not for Human or Veterinary Consumption. Sold by Longevra Research LLC for laboratory use only. Not approved by the FDA. Not intended to diagnose, treat, cure, prevent, or mitigate any disease.

Tirzepatide is a synthetic peptide that activates two receptors at once: the GIP receptor and the GLP-1 receptor. Both belong to the incretin family. Most preclinical tirzepatide papers are asking whether dual-agonism produces a different downstream cAMP response than hitting either receptor alone.

What ships: 30MG per vial · ≥99% HPLC-verified purity · MS-confirmed identity · batch-specific Certificate of Analysis.

Out of stock

Category:
Bulk pricing — auto-applied at checkout
QuantityYou savePer unit
3+5%$175.75
5+10%$166.50
10+15%$157.25
Download Certificate of Analysis

Description

Tirzepatide is a synthetic 39-amino-acid dual agonist peptide engineered to engage both the GIP receptor and the GLP-1 receptor. The 30 mg presentation is intended for laboratory workflows that require larger working quantities, such as extended in vitro time-course studies or rodent pharmacology research where multiple study arms draw from a single batch.

Research Context

Preclinical investigations have examined tirzepatide as a dual incretin receptor agonist in rodent and in vitro models, with research interest in the pharmacology of simultaneous GLP-1 and GIP receptor activation. Laboratory studies have characterized the compound’s binding kinetics, biased signaling profile, and downstream cAMP and beta-arrestin pathway activation in cell-culture systems. Researchers have used tirzepatide in comparative studies alongside selective single-receptor agonists, examining how dual engagement of incretin pathways alters intracellular signaling outcomes relative to single-pathway compounds. This product is offered strictly as a research reagent for in vitro and preclinical metabolic biology research.

Reconstitution & Storage

  • Recommended reconstitution: 4-5 mL bacteriostatic water per 30 mg vial
  • Storage: Lyophilized: 2-8°C (refrigerated), long-term -20°C. Reconstituted: 2-8°C, use within 28 days.
  • Stability: Avoid freeze-thaw cycles. Protect from light.

Quality Specifications

Parameter Specification
Purity ≥99% (HPLC)
Identity Confirmed by mass spectrometry
Form Lyophilized powder
Vial size 30 mg
COA Included with order

Research Use Only Disclaimer

This product is sold strictly for laboratory and scientific research purposes. Not for human consumption, ingestion, or administration. Not intended to diagnose, treat, cure, or prevent any disease. Not approved by the FDA for any clinical use.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide (GLP-1/GIP) 30MG”

Your email address will not be published. Required fields are marked *